Detalles de la búsqueda
1.
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.
Health Qual Life Outcomes
; 22(1): 38, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745165
2.
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.
Oncologist
; 27(8): 675-684, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35552444
3.
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Oncologist
; 26(8): e1327-e1338, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028126
4.
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes.
Breast Cancer Res Treat
; 181(1): 155-165, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236828
5.
Ambulatory Toxicity Management (AToM) in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer - a pragmatic cluster randomized trial protocol.
BMC Cancer
; 19(1): 884, 2019 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31488084
6.
The impact of cancer drug wastage on economic evaluations.
Cancer
; 123(18): 3583-3590, 2017 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28640362
7.
Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.
Cancer
; 122(6): 893-8, 2016 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26696022
8.
Long-term cardiovascular outcomes and overall survival of early-stage breast cancer patients with early discontinuation of trastuzumab: a population-based study.
Breast Cancer Res Treat
; 157(3): 535-44, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27271767
9.
Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D.
Breast Cancer Res Treat
; 150(1): 169-80, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25694355
10.
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy.
Breast Cancer Res Treat
; 153(1): 135-44, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26208483
11.
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
JNCI Cancer Spectr
; 8(1)2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38113421
12.
A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.
Breast Cancer Res Treat
; 137(2): 471-82, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23239151
13.
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012.
Biologicals
; 40(6): 517-27, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23084808
14.
Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.
MDM Policy Pract
; 7(2): 23814683221142267, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36532295
15.
Prediction of chemotherapy response in breast cancer patients at pre-treatment using second derivative texture of CT images and machine learning.
Transl Oncol
; 14(10): 101183, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293685
16.
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update.
J Clin Oncol
; 39(6): 685-693, 2021 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079579
17.
Association of low tumor RNA integrity with response to chemotherapy in breast cancer patients.
Breast Cancer Res Treat
; 119(2): 347-56, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19771508
18.
Detection of later stage breast cancer in First Nations women in Ontario, Canada.
Can J Public Health
; 101(1): 101-5, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20364549
19.
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial.
J Clin Oncol
; 38(27): 3138-3149, 2020 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32678716
20.
High insulin levels in newly diagnosed breast cancer patients reflect underlying insulin resistance and are associated with components of the insulin resistance syndrome.
Breast Cancer Res Treat
; 114(3): 517-25, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18437560